上海德琪医药科技有限公司

公司简介

Antengene Corporation is a clinical-stage drug development company focusing on introducing mid- to late-stage drug candidates from abroad to China, bringing to China Food and Drug Administration (CFDA) approval and launching products for Chinese market Antengene's approach is to leverage global medical innovation from the U.S. and Europe coupled with Antengene's expertise in clinical development and commercialization in Chinese market to alleviate cost pressures of innovators, accelerate product entry into China, expand/defend the business interest of its partners in Chinese market and ultimately meet huge medical needs of Chinese patients.